Through treatment pathways and, ultimately, to outcomes that make a difference to their quality of lifeLearn more
The nature of the journey of the patient
Fully integrated legal and regulation governance
Treat as an individual
Network participants through value
Integrate solutions to leverage smooth process and availability
Guide patients through treatment journey
Manage documentation kits matching regulatory and administrative requirements
The clinical tests access, geo-logistic support in obtaining laboratory results
Remind of upcoming steps and documentation submission terms etc.
Reporting of an undesirable effect of treatment
Managing documentation and guiding through procedures steps
Logistic services and settlement with specialized laboratories
Call center to track compliance, remind upcoming actions
Support procedure for patients, undergoing treatment with biological or biosimilar products
Upon initial contact with the patient, they are presented with a “SAT Health” “Declaration- consent” form, regarding the personal data handling procedures. The patient is given the option to consent/withdraw from the above described personal data handling procedures.
A “SAT Health” assistant provides the patient with detailed information in regard to the application procedure, resulting in treatment access.
A “SAT Health” assistant ensures that the patient, and their detailed documentation, complies with the requirements set out by the EMC. Furthermore, they assist the patient with the collection and completion of said documentation.
A “SAT Health assistant directs the patient, as to where to perform the laboratory tests, and if need arises, provides logistical support and further assistance in obtaining the results by liaising with the laboratory(s).
A “SAT Health” assistant assists the patient in coordination and guidance for the purposes of appearing before the EMC. The assistant performs a further verification of the completeness and correctness of the documentation, including the medical laboratory test results. A key requirement for attaining biological/biosimilar treatment eligibility is, for the patient to have undergone treatment using conventional procedures, resulting in insufficient, or lacking any, effect on their condition.
Upon confirmation of patient eligibility by the EMC, a “SAT Healthcare” assistant outlines the further document submission steps in regard to the RHIF/NHIF. During the process, the assistant keeps track of the submitted documents, their corresponding reference numbers, and the submission deadlines. If the patient cannot follow the procedure due to their medical condition, or other socioeconomic factors, they could authorize a family member, or the “SAT Healthcare” assistant, to submit the documentation on their behalf.
A “SAT Healthcare” assistant further assists the patient in the final steps of the treatment process – gaining access to the medication from a pharmacy.
A “SAT Healthcare” assistant informs the patient of any further appearances before the EMC, for the purposes of treatment tracking, during its complete course.
Adverse Event is any untoward medical occurrence in a patient or clinical investigation subject who has been administered medicinal product, which does not necessarily have to have a causal relationship with this treatment. An AE can be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom or disease occurring during the time the Assignor’s product was used whether or not considered related to the medicinal product.
You can report a suspected adverse event of the medication you are using during your participation in the Program: on the 24-hour phone line: 0700 70009 or send an e-mail to email@example.com.
Valid message must contain minimum necessary information: